Please assess the completion status of the following clinical trial:

Trial Title: Microwave Ablation in Mild Axillary Hidradenitis Suppurativa

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult (≥ 18 years of age) male or female patients with mild HS and able to participate, willing to give written informed consent and to comply with the study restrictions;~* Minimum of 3 AN-count located in each axilla;~* Maximum of 5 AN-count located in each axilla.~Exclusion Criteria:~* Patients with \>1 abscesses or draining fistulas per axillary region;~* AN-count ≥ 5 in other regions than the axillary area;~* Any current and / or recurrent clinically significant skin condition in the treatment area other than HS;~* Surgical scars covering more than 25% of each individual axillary area;~* Open surgical wound(s) in the axillary areas prior to randomization;~* Use of anti-inflammatory or immunomodulatory medication (intralesional corticosteroids, oral antibiotics, biologics, prednisone) within 2 weeks prior to randomization;~* Contraindication for miraDry therapy;~* Heart pacemakers and other electronic device implants;~* Supplemental oxygen;~* Resistance to or history of intolerance of local anesthesia including lidocaine and epinephrine;~* Previous use of miraDry therapy or MWA in the axillary area;~* Previous use of successful laser or light therapy for hair removal in the axillary area;~* Use of botulinum toxin injections 6 months prior to randomization;~* Use of aluminiumhydroxychloride 1 month prior to randomization;~* Pregnant or lactating women at randomization.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Microwave ablation (Type: EXPERIMENTAL): One-sided single microwave ablation (MWA) treatment in one axillary region with a miraDry device.
- No microwave ablation (Type: NO_INTERVENTION): Lesion intervention in the non-MWA treated contralateral axilla consists of once daily topical clindamycin 1% lotion.

Based on this trial design, predict the completion outcome and termination type (if applicable).